Tagged with Investment,

Taiwan Chih-Kung Lee, Minister of Economic Affairs of the Republic of China (Taiwan) provides insights into Taiwan’s “new economic model” recently established by the new government to boost the country’s economic growth and ensure Taiwan renews its role as an innovation pioneer. He also documents the crucial role that the pharmaceutical…

Switzerland Bernhard Neidhart, head of Office for Economy and Labor in Zug, introduces us to the Canton of Zug and explains how the region became a hotspot for pharma.   To begin Dr. Neidhart, could you please introduce us to the Canton of Zug? How does Zug’s “value proposition” compare to…

Philippines Stanislas Camart, President of the French Chamber of Commerce and Industry in the Philippines, discusses the chamber’s rapidly expanding membership and how they continue to evolve and adapt their services to truly add value to their members. He also discusses the unique aspects of Filipino business culture and exciting opportunities…

Ireland In an exclusive interview, Irish Minister for Foreign Affairs and Trade, Charles Flanagan TD, outlines the Department’s enhanced focus on trade and economic recovery, Ireland’s commitment to productive global engagement, and the strategic importance of the life sciences industry to Ireland’s economy.    In 2015, the Irish Government launched a…

Luxembourg Jean-Paul Schuler, CEO of Luxinnovation – Luxembourg’s National Agency for Innovation and Research –, explains how his team is working hard to contribute to Luxembourg’s economic development by fostering innovation, fueling international growth and attracting foreign direct investment. He also explains why Luxembourg is an excellent place for companies looking to…

Czech Republic One of the very first former-communist European states to attain a successful economic transition, the Czech Republic today puts across a compelling argument for being regarded as one of the regional leaders in pharmaceuticals, healthcare and life sciences.   In the Czech Republic we have the right balance between sophisticated…

Switzerland Daniel Küng, CEO of Switzerland Global Enterprise (S-GE), the Swiss export promotion agency, also responsible for promoting Switzerland as a business location, reveals how the increase in the value of the Swiss Franc has brought Swiss companies to become more innovative when it comes to selling their products abroad; how…

Switzerland Thomas Cueni of Interpharma, the Association of Pharmaceutical Research Companies of Switzerland, on the trend of major international companies developing significant operations in Switzerland; how 70 percent of employees at the top pharma companies are foreigners; and why the pharmaceutical industry is the exception to the rule when it comes…

Singapore The executive director of the Singaporean-German Chamber of Industry and Commerce explains the evolution of the business relationship between Singapore and Germany, cultural similarities and challenges, and showcases the chamber as a platform to further enhance bilateral economic relations between the two nations. Could you please introduce to our international…

Switzerland Walter Steinlin describes the Federal Commission of Technology and Innovation as a catalyst for turning research into innovation. Based in Bern, Switzerland, the commission funds research institutes in corporate projects, and provides mentorship and coaching support for start-ups. Could you give our international audience an overview of the Federal Commission…

Slovakia Slovakia has been Europe’s fastest growing economy over the last ten years and the government has identified areas within life sciences as strategic centers for investment in the country. Slovakia has a lot to offer biopharma investors according to Robert Simoncic, head of the Slovak investment and trade development agency…

Switzerland Jean-Daniel Gerber, chairman of the board at SIFEM, explains why job creation should be the focus of DFIs (Development Finance Institutions) such as SIFEM; how ESG, environmental, social and governance issues, are key to a successful investment, and why we should focus on illnesses that are most prevalent in the…